维普中文期刊产品整合服务
21篇 您的检索式:作者名="Falsaperla"
    题名 作者 年代 出处 被引量
1Immunohisto- chemical and molecular analysis in recurrent urethral stricture显示文摘Morgia G Saita A Falsaperla M 2000UrolRes2000,28,5:1
2Immunohistochemical and molecular analysis in recurrent urethral stricture显示文摘Morgia G Saita A Falsaperla M 0,,05:1
3Transurethral resection of prostate:technical progress by bipolar Gyrus plasmakinetic tissue management system显示文摘Falsaperla M Cindolo L Saita A 2007Minerva Urol Nefrol2007,59,2:1
4Infantilespasms syndrome,West syndrome and related phenotypes : Whatwe know in 2013 显示文摘PAVONE P STRIANO P FALSAPERLA R 2014Brain Develop2014,36,9:1
5Matrix metallo proteinases as diagnostic(MM13) and prognostic (MMP 2, MMP-9)markers of prostate cancer显示文摘MorgiaG Falsaperla M Malaponte G 2005Urol Res2005,33,1:1
6Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer显示文摘Morgia G Falsaperla M Malaponte G 2005Urol Res2005,,:1
7Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2,MMP-9) markers of prostate cancer显示文摘Morgia G Falsaperla M Malaponte G 2005Urol Res2005,33,:1
8Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2,MMP-9) markers of prostate cancer显示文摘Morgia G Falsaperla M Malaponte G 2005Urol Res2005,33,1:1
9Infantile spasms syndrome, west syndrome and related phenotypes: What we know in 2013显示文摘Pavone P Striano P Falsaperla R 2013Brain Deu2013,19,13:1
10HyperCKemia as a biomarker for nmscular diseases 显示文摘Falsaperla R Parano E Romano C 2010Clin Ter2010,161,2:1
11Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2,MMP-9) markers of prostate cancer显示文摘Morgia G Falsaperla M Malaponte G 2005Urol Res2005,33,1:1
12Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP- 9 ) markers of prostate cancer 显示文摘Morgia G Falsaperla M Malaponte G 2005Urol Res2005,33,1:1
13Infantile spasms syn- drome, West syndrome and related phenotypes : what we know in 2013显示文摘Pavone P Striano P Falsaperla R 2014Brain Dev2014,36,9:1
14Transurethral resection of prostate: technical progress by bipolar Gyrus plasma-kinetic tissue management system显示文摘Falsaperla M Cindolo L Saita A 2007Minerva Urol Nefrol2007,59,2:1
15metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9)markers of prostate cancer 显示文摘Morgia G Falsaperla M Malaponte G 2004Urol Res2004,,:1
16Haemostatic agents during laparoscopic nephron-sparing surgery:what about TachoSil?显示文摘Falsaperla M Autorino R Puglisi M 2009BJU Int2009,104,2:1
17Tran- surethral resection of prostate: technical progress by bipolar Gyrus plasma-kinetic tissue management system显示文摘FALSAPERLA M CINDOLO L SAITA A 2007Minerva Urol Nefrol2007,59,2:1
18A variational ine- quality model of the spatial price network problem with uncertain data 显示文摘Falsaperla P Raciti F Scrimali L 2012Optimization and Engineer- ing2012,13,3:1
19Hyper CK emia as a biomarker for muscular diseases显示文摘Falsaperla R Parano E Romano C 2010Clin Ter2010,161,2:1
20Transurethral resection of prostate: technical progress by bipolar Cyrus plasmakinetie tissue management system显示文摘Falsaperla M Cindolo L Saita A 2007Minerva Urol Nefrol2007,59,2:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费